Evan Roberts Sells 2,029 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,029 shares of the business’s stock in a transaction dated Monday, April 15th. The shares were sold at an average price of $22.86, for a total value of $46,382.94. Following the completion of the sale, the chief operating officer now directly owns 754,903 shares of the company’s stock, valued at $17,257,082.58. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Evan Roberts also recently made the following trade(s):

• On Monday, April 8th, Evan Roberts sold 7,178 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total value of $162,366.36.
• On Thursday, March 21st, Evan Roberts sold 25,962 shares of Phreesia stock. The shares were sold at an average price of $23.52, for a total value of $610,626.24.

Phreesia Stock Performance

PHR stock opened at $22.62 on Friday. Phreesia, Inc. has a fifty-two week low of $12.05 and a fifty-two week high of $34.98. The stock has a fifty day moving average of $24.40 and a 200-day moving average of $21.26. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.02.

Phreesia (NYSE:PHR) last issued its earnings results on Thursday, March 14th. The company reported ($0.56) EPS for the quarter, topping the consensus estimate of ($0.58) by $0.02. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The business had revenue of $95.00 million during the quarter, compared to the consensus estimate of $93.52 million. During the same quarter last year, the company earned ($0.72) EPS. The firm’s revenue was up 24.0% compared to the same quarter last year. As a group, sell-side analysts forecast that Phreesia, Inc. will post -1.48 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Truist Financial assumed coverage on Phreesia in a research report on Monday, February 26th. They set a “buy” rating and a $35.00 target price for the company. Canaccord Genuity Group raised their target price on Phreesia from $36.00 to $37.00 and gave the company a “buy” rating in a research report on Friday, March 15th. Raymond James reaffirmed an “outperform” rating and set a $30.00 target price (up from $25.00) on shares of Phreesia in a research report on Friday, March 15th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $23.00 target price on shares of Phreesia in a research report on Thursday, March 21st. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 target price on shares of Phreesia in a research report on Friday, March 15th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $31.62.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in PHR. Diversified Trust Co bought a new stake in shares of Phreesia during the 1st quarter valued at about $256,000. WoodTrust Financial Corp boosted its position in shares of Phreesia by 87.9% during the 1st quarter. WoodTrust Financial Corp now owns 31,000 shares of the company’s stock valued at $742,000 after acquiring an additional 14,500 shares during the last quarter. Moody National Bank Trust Division boosted its position in shares of Phreesia by 41.9% during the 1st quarter. Moody National Bank Trust Division now owns 71,044 shares of the company’s stock valued at $1,700,000 after acquiring an additional 20,977 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of Phreesia by 4.4% during the 4th quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock valued at $107,148,000 after acquiring an additional 194,035 shares during the last quarter. Finally, American International Group Inc. boosted its position in shares of Phreesia by 2.3% during the 4th quarter. American International Group Inc. now owns 26,342 shares of the company’s stock valued at $610,000 after acquiring an additional 591 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.